Jagsonpal Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

298.05 +4.25 ▲1.5%

22 March 2023, 11:44:47 AM
Volume: 2,726

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jagsonpal.com
Market Cap 780.83 Cr.
Enterprise Value(EV) 726.59 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 7.10 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 42.01 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 52.70 Trailing Twelve Months Ending 2022-12
Price to Book Value 5.66 Calculated using Price: 298.05
Dividend Yield 1.34 Period Ending 2022-03
No. of Shares Subscribed 2.62 Cr. 26,198,000 Shares
FaceValue 5
Company Profile
In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar's vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India's premiere pharmaceutical companies.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.45%
1 Week
+0.54%
1 Month
-8.08%
3 Month
-17.88%
6 Month
-22.41%
1 Year
-1.26%
2 Year
+273.73%
5 Year
+991.76%
10 Year
+2880.50%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.47 1.35 3.65 12.32 -12.01 7.72 7.88 15.70 16.52
Return on Capital Employed (%) 6.57 4.93 7.32 14.26 -10.52 9.80 9.46 19.43 22.64
Return on Assets (%) 1.37 0.75 2.08 7.86 -8.48 5.43 5.53 10.90 11.78

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 99 95 98 110 98 104 111 122 131 138
Non Curr. Liab. 4 4 4 3 3 3 3 2 3 6
Curr. Liab. 54 55 57 29 29 28 35 40 34 21
Minority Int.
Equity & Liab. 156 154 159 143 130 136 149 164 168 166
Non Curr. Assets 65 58 58 33 35 38 52 44 58 52
Curr. Assets 91 96 101 110 95 98 96 120 111 114
Misc. Exp. not W/O
Total Assets 156 154 159 143 130 136 149 164 168 166

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 144 138 143 144 127 167 159 188 226 233
Other Income 0 0 1 0 0 1 3 4 3 3
Total Income 144 138 144 144 127 168 161 192 229 237
Total Expenditure -133 -129 -132 -138 -138 -157 -150 -169 -200 -205
PBIDT 11 9 12 6 -11 11 11 23 29 32
Interest -5 -4 -5 -3 -1 -1 -1 -1 0 0
Depreciation -3 -3 -3 -2 0 -1 -1 -1 -2 -1
Taxation 0 -1 -1 -3 0 -2 -2 -5 -8 -6
Exceptional Items 13 -6
PAT 2 1 3 12 -12 7 8 17 20 19
Adjusted EPS 1 0 1 5 -4 3 3 7 7 7

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 12 8 4 9 -3 -2 31 12 28 6
Cash Fr. Inv. -3 -1 0 -2 41 -3 -1 -11 -2 -26
Cash Fr. Finan. -8 -4 -1 -6 -34 -1 -6 -2 -7 -12
Net Change 0 2 2 1 5 -6 24 -1 19 -33
Cash & Cash Eqvt 10 13 15 16 20 15 39 40 59 26

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 70.34 70.34 70.34 70.34 70.34 68.71 68.71 68.72 68.71
Public 29.66 29.66 29.66 29.66 29.66 31.29 31.29 31.28 31.29
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 14 Feb 2023
Updates
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'We wish to inform you that consequent to the appointment of Mr. Abhishek Joshi as Company Secretary, theBoard of Directors have approved changes in KMPs authorized for the purpose of d
Tue, 14 Feb 2023
Change in Company Secretary/Compliance Officer
Jagsonpal Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer
Thu, 09 Feb 2023
Outcome of Board Meeting
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 08, 2023.

Technical Scans View Details >>

Tue, 21 Mar 2023
Opening at High Opening at High
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 962.00 +0.6%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,439.95 +0.5%
Divi's Laboratories Ltd. 73,553.38 2,779.95 +0.4%
Cipla Ltd. 69,632.88 855.10 -0.8%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,230.05 -1.0%
Torrent Pharmaceuticals Ltd. 51,277.87 1,510.30 -0.3%
Zydus Lifesciences Ltd. 48,378.30 478.90 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 962.00 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,439.95 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,779.95 +0.4%
Cipla Ltd. Consolidated 2022-12 26.39 855.10 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,230.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,510.30 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 478.90 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 962.00 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,439.95 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,779.95 +0.4%
Cipla Ltd. Consolidated 2022-12 3.07 855.10 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,230.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,510.30 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 478.90 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 962.00 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,439.95 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,779.95 +0.4%
Cipla Ltd. Consolidated 2022-03 0.04 855.10 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,230.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,510.30 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 478.90 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 962.00 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,439.95 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,779.95 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 855.10 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,230.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,510.30 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 478.90 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 962.00 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,439.95 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,779.95 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 855.10 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,230.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,510.30 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 478.90 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 962.00 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,439.95 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,779.95 +0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 855.10 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,230.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,510.30 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 478.90 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 962.00 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,439.95 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,779.95 +0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 855.10 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,230.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,510.30 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 478.90 +0.1%

FAQ's On Jagsonpal Pharmaceuticals Ltd.

What is Jagsonpal Pharma share price?
Can I buy Jagsonpal Pharma shares now?
What is the Dividend Yield of Jagsonpal Pharma?
What is the Market Cap of Jagsonpal Pharma?
What are the key metrics to analyse Jagsonpal Pharma?
What is the 52 Week High and Low of Jagsonpal Pharma?
What is the trend of Jagsonpal Pharma share price?